3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hodgkin Disease
3
Breast Neoplasms
3
Lymphoma, Non-Hodgkin
2
Leukemia
2
Triple Negative Breast Neoplasms
1
Teratoma
1
Rhabdomyosarcoma
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Pain
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, AIDS-Related
1
Lymphoma
1
Leukemia, Myeloid, Acute
1
Inflammatory Breast Neoplasms
1
Infiltrating Bladder Urothelial Carcinoma
1
Glioma
1
Choriocarcinoma
1
Central Nervous System Neoplasms
1
Carcinoma, Embryonal
1
Burkitt Lymphoma
1
Adenocarcinoma, Bronchiolo-Alveolar
1
Adenocarcinoma of Lung
1
Interventions
Cisplatin
14
Paclitaxel
12
pembrolizumab
9
Fluorouracil
7
Radiotherapy
6
Irinotecan
5
Esophagectomy
5
tislelizumab
4
Oxaliplatin
4
Leucovorin
4
Drug Therapy
4
Carboplatin
4
toripalimab
3
Levoleucovorin
3
Docetaxel
3
Capecitabine
3
camrelizumab
2
Taxes
2
Radiation
2
Nivolumab
2
Injections
2
130-nm albumin-bound paclitaxel
2
spartalizumab
1
sintilimab
1
palbociclib
1
nimotuzumab
1
nazartinib
1
lenvatinib
1
ivarmacitinib
1
futibatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Esophageal Squamous Cell Carcinoma
×
pegfilgrastim
×
90 days
×
Clear all
No trials found.